Research advances in invasion mechanism and inhibitors of 2019-nCoV
返回论文页
|更新时间:2023-12-22
|
Research advances in invasion mechanism and inhibitors of 2019-nCoV
Journal of Chongqing Medical UniversityVol. 45, Issue 7, Pages: 845(2020)
作者机构:
1. 重庆医科大学检验医学院临床检验诊断重点实验室,重庆,400016
2. 重庆医科大学感染性疾病分子生物学教育部重点实验室,重庆,400016
作者简介:
基金信息:
DOI:
CLC:
Published:2020,
扫 描 看 全 文
Shi Yueyuan, Wang Deqiang. Research advances in invasion mechanism and inhibitors of 2019-nCoV. [J]. Journal of Chongqing Medical University 45(7):845(2020)
DOI:
Shi Yueyuan, Wang Deqiang. Research advances in invasion mechanism and inhibitors of 2019-nCoV. [J]. Journal of Chongqing Medical University 45(7):845(2020)DOI:
Research advances in invasion mechanism and inhibitors of 2019-nCoV
The pathogen was identified as a new type of coronavirus and named as 2019-nCoV. The nucleic acids and encoded viral proteins of 2019-nCoV and SARS-CoV are highly homologous,indicating that their biological functions may also be very similar. 2019-nCoV uses the S1 subunit of its spike protein binding to the ACE2 receptor on the surface of the host cell,and uses the host protease to cleave the S protein to promote membrane fusion and then endocytosis. Inhibitors that blocking 2019-nCoV invasion can be divided into neutralizing antibody/receptor inhibitors,protease inhibitors,and endocytosis regulator inhibitors. At present,the under-standing of 2019-nCoV is still very limited. It is believed that with the continuous advancement of research,we can better understand the pathogenic mechanism of the virus and develop more efficient antiviral drugs.